Tekla Capital Management’s MacroGenics MGNX Stock Holding History

Tekla Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-12,743	Closed	-$273K	–	150
2015 Q3	$273K	Hold	12,743	–	–	0.01%	159
2015 Q2	$484K	Hold	12,743	–	–	0.02%	111
2015 Q1	$400K	Hold	12,743	–	–	0.02%	114
2014 Q4	$447K	Sell	12,743 -19,114	-60%	-$476K	0.02%	89
2014 Q3	$666K	Hold	31,857	–	–	0.03%	106
2014 Q2	$692K	Hold	31,857	–	–	0.06%	62
2014 Q1	$798K	Hold	31,857	–	–	0.08%	61
2013 Q4	$786K	Buy	+31,857	New	+$833K	0.08%	57

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Tekla Capital Management's MGNX Position: Q4 2015 in Review

Tekla Capital Management sold out of MacroGenics (MGNX) in Q4 2015, closing a stake of 12,743 shares — an estimated $273K sold.

Tekla Capital Management first reported a position in MGNX in Q4 2013 and held it in 8 quarters. The position peaked at $798K in Q1 2014. 128 funds tracked by Wall St. Rank hold MGNX as of Q4 2015.

Tekla Capital Management reported no remaining MacroGenics position as of Q4 2015 after selling out during the quarter.
Tekla Capital Management sold 12,743 MacroGenics shares in Q4 2015, an estimated $273K.
Tekla Capital Management first reported a position in MacroGenics in Q4 2013 and held it in 8 quarters.
Tekla Capital Management's MacroGenics position peaked at $798K in Q1 2014.
128 funds tracked by Wall St. Rank held MacroGenics as of Q4 2015.

Based on Tekla Capital Management's 13F filing for Q4 2015, filed 9 Feb 2016.